Roisman LC, Mann S, Basel A, Marei R, et al. The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pe Clin Lung Cancer 2025 Feb 13:S1525-7304(25)00027.
PMID: 40064573